Paclitaxel + Carboplatin
Information
- Drug Name
- Paclitaxel + Carboplatin
- Description
- Entry(CIViC)
CIViC
[No Data.]
Annotation
Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
---|---|---|---|---|---|---|
In this phase II trial (metastatic melanoma), beva... | VEGFA | VEGFA UNDEREXPRESSION | Sensitivity | true | MMMP | detail |
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03168880 | Active, not recruiting | Phase 3 | A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer | April 2010 | November 30, 2025 |
NCT02453282 | Active, not recruiting | Phase 3 | Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) | July 21, 2015 | December 31, 2024 |
NCT02542293 | Active, not recruiting | Phase 3 | Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | November 3, 2015 | December 31, 2024 |
NCT03003962 | Active, not recruiting | Phase 3 | Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) | January 2, 2017 | June 3, 2026 |
NCT00298415 | Completed | Phase 3 | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | March 2006 | December 2011 |
NCT00516724 | Completed | Phase 1 | Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel | June 22, 2007 | April 11, 2024 |
NCT02658214 | Completed | Phase 1 | Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors | April 28, 2016 | November 14, 2019 |
NCT00254891 | Terminated | Phase 3 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | November 2005 | July 2008 |